Literature DB >> 2402265

The cause of the eosinophilia-myalgia syndrome associated with tryptophan use.

K Sakimoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2402265     DOI： 10.1056/NEJM199010043231412

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Identification of decomposition products of 1,1'-ethylidenebis [L-tryptophan], a compound associated with eosinophilia-myalgia syndrome.

Authors:  W J Driskell; D L Ashley; J Grainger; S R Sirimanne; E P Mazzola; S W Page; L L Needham; R H Hill
Journal:  Bull Environ Contam Toxicol       Date:  1992-05       Impact factor: 2.151

2.  Tryptophan and eosinophilia-myalgia syndrome.

Authors:  P A Hertzman; R R Brown
Journal:  West J Med       Date:  1991-02

3.  Abnormalities of the coronary arteries, neural structures and conduction system of the heart observed postmortem in the eosinophilia-myalgia syndrome, with a discussion of comparative findings from the toxic oil syndrome.

Authors:  T N James
Journal:  Trans Am Clin Climatol Assoc       Date:  1991

4.  Endogenous formation of 1-methyl-1,2,3,4-tetrahydro-beta-carboline-3- carboxylic acid in man as the possible causative substance of eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan.

Authors:  J Adachi; K Yamamoto; Y Ogawa; Y Ueno; Y Mizoi; Y Tatsuno
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

5.  Accumulation of 1-methyl-tetrahydro-beta-carboline-3-carboxylic acid in blood and organs of rat. A possible causative substance of eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan.

Authors:  Y Ogawa; J Adachi; Y Tatsuno
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

6.  Metabolism and distribution in the rat of peak E substance, a constituent in L-tryptophan product implicated in eosinophilia-myalgia syndrome.

Authors:  J Adachi; T Naito; Y Ueno; Y Ogawa; I Ninomiya; Y Tatsuno
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.